Sage Journals: Discover world-class research

Retricted access

Research article

First published 2022-11

Observed Apixaban Anti-Xa Levels in Obese Patients

Weston Harkness, Olivia Pipitone, Jacqueline Joss [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2025-6

Utility of Anti-Xa Levels in Lung Transplant Recipients on Apixaban

Jules Fuentebella, Erwin H. Lam, Rhiannon Garcia [...]

Progress in Transplantation

Retricted access

Research article

First published 2022-12

Evaluation of Anti-Xa Apixaban and Rivaroxaban Levels With Respect to Known Doses in Relation to Major Bleeding Events

Steffany N. Nguyen, Melanie C. Ruegger, Eric Salazar [...]

Journal of Pharmacy Practice

Open access

Research article

First published 2024

Anti-Xa Monitoring of Apixaban (ZyQuis) in Venous Thrombo-Embolism and Atrial Fibrillation

Elise Schapkaitz, Byron Ter Morshuizen, Melanie Mc Cree [...]

Clinical and Applied Thrombosis/Hemostasis

Retricted access

Research article

First published 2018-3

Comparison of Anti-Xa Activity in Patients Receiving Apixaban or Rivaroxaban

David A. Bookstaver, Kimberly Sparks, Brandon S. Pybus [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2019-4

Anti-Xa Oral Anticoagulant Plasma Concentration Assay in Real Life: Rivaroxaban and Apixaban Quantification in Emergency With LMWH Calibrator

Paul Billoir, Virginie Barbay, Luc Marie Joly [...]

Annals of Pharmacotherapy

Retricted access

Case report

First published 2023-4

Low-Molecular-Weight Heparin Anti-Xa Guided Reversal of Apixaban With Prothrombin Complex Concentrate in a Patient on Hemodialysis

Christina M. Brummett, James S. Dingman, George J. Philip [...]

Journal of Pharmacy Practice

Retricted access

Research article

First published 2021

Apixaban and Rivaroxaban Anti-Xa Level Monitoring Versus Standard Monitoring in Hospitalized Patients With Acute Kidney Injury

William Towers, Steffany N. Nguyen, Melanie C. Ruegger [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2026-2

A Single Health System Retrospective Qualitative Analysis of Inpatient Apixaban and Rivaroxaban Calibrated Anti-Xa Level Monitoring and Clinical Implications

Bailey McCarville, Jennifer Osborn

Hospital Pharmacy

Retricted access

Review article

First published 2019-6

Andexanet Alfa: A Recombinant Modified Human Factor Xa Protein for Drug Reversal of Rivaroxaban and Apixaban

Irene Abuan, Kristine H. Wong, Benjamin Bolinske [...]

Journal of Pharmacy Technology

Search results